mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
5e-12 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-09 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
7e-09 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
5e-08 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
8e-08 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
5e-07 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
8e-07 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-06 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-06 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-06 |